International Biotechnology (LON:IBT) Stock Price Crosses Above 200 Day Moving Average – Should You Sell?

International Biotechnology (LON:IBT)’s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 945.04 and traded as high as GBX 970. International Biotechnology shares last traded at GBX 966, with a volume of 39,518 shares changing hands.

International Biotechnology Stock Performance

The company has a debt-to-equity ratio of 9.43, a quick ratio of 0.32 and a current ratio of 0.11. The firm has a market cap of £308.10 million, a P/E ratio of -294.22 and a beta of 0.32. The firm’s fifty day moving average price is GBX 961.08 and its 200 day moving average price is GBX 945.04.

International Biotechnology (LON:IBT) last posted its quarterly earnings results on Tuesday, May 12th. The company reported GBX (4.83) EPS for the quarter. The business had revenue of GBX 24 million during the quarter. International Biotechnology had a net margin of 82.27% and a return on equity of 27.35%. Sell-side analysts expect that International Biotechnology will post 0.9435943 EPS for the current fiscal year.

About International Biotechnology

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.